Philip Morris Cyprus Ltd (PMC), is an affiliate of Philip Morris international (PMI), the global leader in the production and commercialization of smoke-free tobacco products and cigarettes, that was established in April 2021 to better support its smoke-free products that is already selling in the market of Cyprus for the last 5 years. Guided by scientific data and technology, PMC is working intensively for the implementation of its parent company vision for a smoke-free future. In July 2020, the US Food and Drug Administration (FDA) approved IQOS, marking it as a modified risk tobacco product, suitable for promoting public health. By March 2022, approximately 12,7 million adult smokers around the world, excluding Russia and Ukraine, and more than 50.000 in Cyprus i.e. 1 out of 4, have chosen this new technology, available in 71 countries. Cyprus marks one out of the 10 PMI’s markets where over 50% of its revenue is generated by heated tobacco products. Having a consumer-centric approach, the company has a complete presence in the Cypriot market with a wide network of stores, e-commerce and customer care support as well as partnerships with retail outlets and technology chains. PMC actively supports small retail and its partners by annually investing 1 million euros. It offers a high-quality working environment, currently employing over 100 direct and indirect employees, with more than 50% of the positions being filled by women. As its smoke-free product portfolio expands, better alternatives are offered for any adult smoker who wants to switch and leave the conventional cigarette behind.
More information about the company's actions can be found at www.pmi.com